Citius Pharmaceuticals, Inc.
Late-stage biopharma developing critical care products for oncology, infections, and stem cells.
CTXR | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11 COMMERCE DRIVE, 7016 CRANFORD
- Website:
- https://www.citiuspharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products. The company's diversified pipeline includes anti-infectives, adjunct cancer care therapies, and stem cell therapies. Its portfolio features the FDA-approved LYMPHIR™, a targeted oncology therapy, and Mino-Lok®, an anti-infective product candidate. Citius aims to address unmet medical needs through the development of innovative treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Citius Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Citius Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Citius Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
